Clinical Trial Update: Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE Study

View source ↗

Summary

This completed observational real-world evidence study assesses patient-reported wellbeing with tildrakizumab in plaque psoriasis. The POSITIVE study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Tildrakizumab (tildrakizumab)

Snippet

Sponsor: Almirall, S.A. | Conditions: Plaque Psoriasis | Status: COMPLETED